Primary Image

Plum abstract header

Clinical Trial

Evaluating chemotherapy related sensorimotor dysfunction in cancer survivors

IRB Protocol Number STU00209528

Contact

Allison Wang bwang15@u.northwestern.edu

Objective

The purpose of this study is to understand how chemotherapy affects sensation and movement function.

There are two main objectives:

1) to measure how the nervous system responds to quick small perturbations to the arm;

2) to assess nerve function in the arm.

We are recruiting healthy individuals. Data collected from healthy individuals will be used as comparison for cancer survivors.

Who Can Participate

Healthy individuals between ages of 40-70

Compensation

Provided upon participation.

Age Range

40-70

Apply for this Trial

Your information will not be published.

All fields are required.

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all